Shattuck Labs Inc（STTK）の財務STTKShattuck Labs Inc

Evaluating the bottom line, Shattuck Labs Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -39.21%, provide a clear picture of how effectively STTK converts its operational activities into shareholder value.

In the context of the broader market, STTK competes directly with industry leaders such as DRUG and CLYM. With a market capitalization of $582.61M, it holds a leading position in the sector. When comparing efficiency, STTK's gross margin of N/A stands against DRUG's N/A and CLYM's N/A. Such benchmarking helps identify whether Shattuck Labs Inc is trading at a premium or discount relative to its financial performance.

The company has reported total revenue of $1 million in Q3 2025, with a gross margin of 100% for that quarter. However, it has also shown significant net losses, with a net income of -$10,056,000 for the same quarter, indicating ongoing challenges in achieving profitability.